Sfoglia per AUTORE
BOGLIONE L
Collezione ASL Città di Torino

  

Items : 35

Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116678. doi: 10.1016/j.biopha.2024.116678. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Stroffolini G; Lupia T; De Nicolò A; Antonucci M; Chiara F; Mula J; Palermiti A; Manca A; Boglione L; Cusato J;

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.
2022
ASL Città di Torino

Smedile A; D'Avolio A; Cantù M; Di Perri G; Saracco GM; Cariti G; Manca A; Mula J; Antonucci M; Ciancio A; Palermiti A; Avataneo V; Troshina G; Caviglia GP; Mornese Pinna S; De Nicolò A; Boglione L; Cusato J;

Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers. in The Journal of steroid biochemistry and molecular biology / J Steroid Biochem Mol Biol. 2021 Jun;210:105854. doi: 10.1016/j.jsbmb.2021.105854. Epub 2021 Feb 22.
2021
AOU San Luigi di Orbassano
ASL Città di Torino

Leoni V; Poli G; Di Perri G; Lembo D; Biasi F; D'Avolio A; Cusato J; Civra A; Boglione L; Caccia C;

Co-infection with other respiratory pathogens in COVID-19 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2021 Feb;27(2):297-298. doi: 10.1016/j.cmi.2020.08.012. Epub 2020 Aug 19.
2021
ASL Città di Torino

Calcagno A; Di Perri G; Boglione L; Bonora S; Ghisetti V; Allice T; Trunfio M; Burdino E;

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy. in Journal of hepatology / J Hepatol. 2021 Apr;74(4):801-810. doi: 10.1016/j.jhep.2020.11.017. Epub 2020 Nov 19.
2021
ASL Città di Torino

Ceccherini-Silberstein F; García F; Sarrazin C; Lampertico P; Zeuzem S; Santos J; Gennari W; Figueruela B; Schreiber J; Fernández-Fuertes E; Boglione L; Muñoz-Medina L; Stauber R; Ghisetti V; Graf C; Sighinolfi L; Téllez F; Zoller H; Degasperi E; Paolucci S; Peiffer KH; Lara M; Pardo MR; Kremer AE; Merino D; Vermehren J; Di Maio VC; de Salazar A; Dietz J; et alii...

2021
ASL Città di Torino

Lipani F; Nigra M; D'Avolio A; Bonora S; Di Perri G; Calcagno A; Ghisetti V; Emanuele T; Trunfio M; Faraoni S; Boglione L; Burdino E; Audagnotto S;

Antiviral Therapy in Patients With Hepatitis B Virus Treated for Tuberculosis: A Forgotten Issue. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2020 Sep 12;71(6):1583-1584. doi: 10.1093/cid/ciz1199.
2020
ASL Città di Torino

Lipani F; Boglione L; Lucchini AM; Salvador E; De Benedetto I; Lupia T; Di Perri G;

Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders. in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy / J Infect Chemother. 2020 Jan;26(1):18-22. doi: 10.1016/j.jiac.2019.06.004. Epub 2019 Jul 10.
2020
ASL Città di Torino

Boglione L; Lupia T; Cariti G; Di Perri G;

Plasmatic and intracellular concentration of entecavir during treatment of a symptomatic flare in HBV-HDV decompensated cirrhosis. in Journal of infection and public health / J Infect Public Health. 2020 Feb;13(2):315-316. doi: 10.1016/j.jiph.2019.12.005. Epub 2020 Jan 15.
2020
ASL Città di Torino

Boglione L; De Benedetto I; Salvador E; Lupia T; De Nicolò A; Di Perri G; Lipani F; Lucchini AM;

2020
ASL Città di Torino

Lupia T; Cariti G; Perri GD; Boglione L; Benedetto ID;

2020
ASL Città di Torino

Lupia T; Corcione S; Boglione L; Cariti G; De Rosa FG;

Antiviral treatment with pegylated interferon and clinical outcomes in a cohort of immigrants patients affected by hepatitis delta: A retrospective analysis. in Journal of medical virology / J Med Virol. 2019 Jul;91(7):1329-1334. doi: 10.1002/jmv.25438. Epub 2019 Mar 4.
2019
ASL Città di Torino

Boglione L; Lupia T; Cariti G; Ghisetti V; Milia MG; Burdino E; Di Perri G;

2019
ASL Città di Torino

Boglione L; De Nicolò A; Di Perri G; D'Avolio A;

Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22
2018
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.
2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;

Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. in Pharmacogenomics / Pharmacogenomics. 2018 Jun 1;19(8):701-707. doi: 10.2217/pgs-2018-0009. Epub 2018 May 23.
2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Pinna SM; Carcieri C; Guido F; Cariti G; Di Perri G; D'Avolio A;

Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis. in Journal of medical virology / J Med Virol. 2018 Jun;90(6):1047-1052. doi: 10.1002/jmv.25038. Epub 2018 Mar 15.
2018
ASL Città di Torino

Boglione L; Cariti G; Ghisetti V; Burdino E; Di Perri G;

Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.
2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;

Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. in Archives of virology / Arch Virol. 2018 Apr;163(4):961-967. doi: 10.1007/s00705-017-3684-7. Epub 2018 Jan 9.
2018
ASL Città di Torino

Boglione L; Cusato J; Pinna SM; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Combination therapy in chronic hepatitis B: what are the real benefits? in Minerva medica / Minerva Med. 2018 Apr;109(2):69-70. doi: 10.23736/S0026-4806.17.05474-X. Epub 2017 Nov 7.
2018
ASL Città di Torino

Boglione L; Cariti G;

2018
ASL Città di Torino

Silberstein FC; Cento V; Perno CF; Andreoni M; Angelico M; Sarmati L; Parruti G; Pasquazzi C; Craxi A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Rendina MG; Pellicelli A; Gubertini GA; Babudieri S; Bonora S; Boglione L; D'ambrosio R; Vullo V; Rossetti B; Zazzi M; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...

2018
ASL Città di Torino

Ceccherini-Silberstein F; Perno CF; Cento V; Andreoni M; Angelico M; Parruti G; Sarmati L; Pasquazzi C; Craxì A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Pellicelli A; Rendina M; Gubertini G; Babudieri S; Bonora S; Boglione L; D'Ambrosio AR; Vullo V; Zazzi M; Rossetti B; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...

2018
ASL Città di Torino

De Nicolò A; Boglione L; Cusato J; Fatiguso G; Favata F; Allegra S; Cariti G; Di Perri G; D'Avolio A;

2018
ASL Città di Torino

Boglione L; Pinna SM; Lupia T; Cariti G; Di Perri G;

Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Sep;53:195-198. doi: 10.1016/j.meegid.2017.05.026. Epub 2017 Jun 1.
2017
ASL Città di Torino

Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3. in European journal of public health / Eur J Public Health. 2017 Oct 1;27(5):938-941. doi: 10.1093/eurpub/ckx025.
2017
ASL Città di Torino

Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Influence of ABCB11 and HNF4? genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.
2017
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study. in Journal of viral hepatitis / J Viral Hepat. 2017 Oct;24(10):850-857. doi: 10.1111/jvh.12711. Epub 2017 Apr 25.
2017
ASL Città di Torino

Boglione L; Mornese Pinna S; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):607-611. doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.
2017
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.
2017
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Imbornone R; Cardellino CS; Ghisetti V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Jun;49(6):705-708. doi: 10.1016/j.dld.2017.01.144. Epub 2017 Jan 17.
2017
ASL Città di Torino

Boglione L; De Nicolò A; Mornese Pinna S; Cusato J; Favata F; Ariaudo A; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Jul;51:167-172. doi: 10.1016/j.meegid.2017.03.014. Epub 2017 Mar 16.
2017
ASL Città di Torino

Boglione L; Cardellino CS; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. in Infection / Infection. 2017 Feb;45(1):103-106. doi: 10.1007/s15010-016-0962-3. Epub 2016 Nov 16.
2017
ASL Città di Torino

Boglione L; Pinna SM; Cardellino CS; De Nicolò A; Cusato J; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Epidemiology, patient profile, and health care resource use for hepatitis C in Italy. in ClinicoEconomics and outcomes research : CEOR / Clinicoecon Outcomes Res. 2017 Oct 10;9:609-616. doi: 10.2147/CEOR.S136456. eCollection 2017.
2017
ASL Città di Torino

Sangiorgi D; Perrone V; Buda S; Boglione L; Cariti G; Lefevre C; Nappi C; Degli Esposti L;

UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.
2016
ASL Città di Torino

Di Perri G; Tomasello C; Pensi D; Cusato J; Boglione L; Bonifacio G; De Nicolò A; D'Avolio A;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte